HealthCor Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

HealthCor Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-82,183	Closed	-$11.4M	–	98
2021 Q3	$11.4M	Buy	82,183 +71,183	+647%	+$8.89M	0.49%	41
2021 Q2	$1.07M	Buy	+11,000	New	+$893K	0.04%	67
2019 Q2	–	Sell	-152,040	Closed	-$7.83M	–	71
2019 Q1	$7.83M	Buy	+152,040	New	+$6.57M	0.32%	44

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HealthCor Management's BHVN Position: Q4 2021 in Review

HealthCor Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2021, closing a stake of 82,183 shares — an estimated $11.4M sold.

HealthCor Management first reported a position in BHVN in Q1 2019 and held it in 3 quarters. The position peaked at $11.4M in Q3 2021. 284 funds tracked by Wall St. Rank hold BHVN as of Q4 2021.

HealthCor Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2021 after selling out during the quarter.
HealthCor Management sold 82,183 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2021, an estimated $11.4M.
HealthCor Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 3 quarters.
HealthCor Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $11.4M in Q3 2021.
284 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2021.

Based on HealthCor Management's 13F filing for Q4 2021, filed 14 Feb 2022.